Inventor · disambiguated record
Muhammad Ashraf
Also filed as: ASHRAF MUHAMMAD · ASHRAF MUHAMMAD WAQAR
12 granted patents·10 pending applications·69 citations·filing 2003–2024
89Inventor score
Top patents by PatentIndex Score
22 records- 0197US10913050B1Method for making and using a dye sorbentUNIV PRINCE MOHAMMAD BIN FAHD·Filed 2020·Granted Feb 9, 2021·7 cites·5 claims
- 0287US7446111B2Amorphous rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid and its pharmaceutical compositionsWYETH CORP·Filed 2007·Granted Nov 4, 2008·12 cites·27 claims
- 0386US8790708B2Coated tablet formulations and uses thereofWYETH LLC·Filed 2013·Granted Jul 29, 2014·14 cites·23 claims
- 0486US8518446B2Coated tablet formulations and uses thereofASHRAF MUHAMMAD·Filed 2010·Granted Aug 27, 2013·20 cites·18 claims
- 0584US11660583B2Treatment method for forming a dye sorbentUNIV PRINCE MOHAMMAD BIN FAHD·Filed 2022·Granted May 30, 2023·0 cites·9 claims
- 0684US11618007B2Method for sulfonating and oxidizing sawdust to form a sorbentUNIV PRINCE MOHAMMAD BIN FAHD·Filed 2022·Granted Apr 4, 2023·0 cites·10 claims
- 0780US7271177B2Amorphous rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid and its pharmaceutical compositionsWYETH CORP·Filed 2004·Granted Sep 18, 2007·14 cites·49 claims
- 0879US11654417B2Method for sulfonating sawdust to form modified sorbentUNIV PRINCE MOHAMMAD BIN FAHD·Filed 2022·Granted May 23, 2023·0 cites·11 claims
- 0972US11471858B2Method of producing modified sawdust sorbentUNIV PRINCE MOHAMMAD BIN FAHD·Filed 2020·Granted Oct 18, 2022·0 cites·11 claims
- 1071US10443044B2Generating cardiac progenitor cells from pluripotent stem cells using isoxazole or isoxazole like compoundsASHRAF MUHAMMAD·Filed 2016·Granted Oct 15, 2019·1 cites·12 claims
- 1165US11248448B2Despiking reservoir propertiesSAUDI ARABIAN OIL CO·Filed 2020·Granted Feb 15, 2022·1 cites·17 claims
- 1263US2024392252A1Generating cardiac progenitor cells from pluripotent stem cells using isoxazole or isoxazole like compoundsIPS HEART·Filed 2024·Application pending·0 cites
- 1357US2021054344A1Cpc exosomes mirna373 combination therapiesIPS HEART·Filed 2020·Application pending·0 cites
- 1451US2004077677A1Oral formulationsWYETH CORP·Filed 2003·Application pending·0 cites
- 1550US2018273906A1Microvesicle and stem cell compositions for therapeutic applicationsASHRAF MUHAMMAD·Filed 2018·Application pending·0 cites
- 1649US2008161336A1Orally bioavailable CCI-779 formulationsWYETH CORP·Filed 2008·Application pending·0 cites
- 1748US2015297638A1Chemically induced pluripotent stem cells for safe therapeutic applicationsASHRAF MUHAMMAD·Filed 2014·Application pending·0 cites
- 1845US2005142192A1Oral administration of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl] phosphonic acid and derivativesWYETH CORP·Filed 2004·Application pending·0 cites
- 1944US2006183766A1Orally bioavailable CCI-779 formulationsWYETH CORP·Filed 2006·Application pending·0 cites
- 2040US11954793B2Systems and methods for three-dimensional facies model generationSAUDI ARABIAN OIL CO·Filed 2022·Granted Apr 9, 2024·0 cites·20 claims
- 2140US2005152983A1Directly compressible pharmaceutical composition for the oral administration of CCI-779WYETH CORP·Filed 2005·Application pending·0 cites
- 2237US2016076001A1Chemically treated induced pluripotent stem cells for safe therapeutic applicationsASHRAF MUHAMMAD·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Muhammad Ashraf files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →